Saldarriaga, Wilmar http://orcid.org/0000-0001-7815-4390
Forero-Forero, Jose Vicente
González-Teshima, Laura Yuriko
Fandiño-Losada, Andrés
Isaza, Carolina
Tovar-Cuevas, Jose Rafael
Silva, Marisol
Choudhary, Nimrah S.
Tang, Hiu-Tung
Aguilar-Gaxiola, Sergio
Hagerman, Randi J.
Tassone, Flora
Article History
Received: 11 April 2017
Revised: 5 December 2017
Accepted: 15 December 2017
First Online: 29 January 2018
Compliance with ethical standards
:
: RJH has received funding from Alcobra, Neuren, Novartis, Roche, and Marinus regarding treatment studies in fragile X syndrome. RJH has also consulted with Zynerba and Ovid regarding treatment studies in fragile X syndrome. FT has received funding from Asuragen, Inc.